title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
103 Biggest Movers From Yesterday,20220511T102237,https://www.benzinga.com/news/22/05/27130447/103-biggest-movers-from-yesterday,SGEN,0.06399,Neutral,0.011826
"Earnings Scheduled For April 28, 2022",20220428T085040,https://www.benzinga.com/news/earnings/22/04/26860440/earnings-scheduled-for-april-28-2022,SGEN,0.014477,Neutral,-0.108204
Pyxis Oncology M&A Spotlight Signals Potential Growth Amidst Competitive ADC Landscape: Analyst - Pyxis Oncology  ( NASDAQ:PYXS ) ,20230905T164314,https://www.benzinga.com/general/biotech/23/09/34244004/pyxis-oncology-m-a-spotlight-signals-potential-growth-amidst-competitive-adc-landscape-analyst,SGEN,0.277433,Neutral,0.087105
Impel Pharmaceuticals Announces Appointment of Darren Cline to the Board of Directors - Impel Pharmaceuticals  ( NASDAQ:IMPL ) ,20230412T200100,https://www.benzinga.com/pressreleases/23/04/g31776707/impel-pharmaceuticals-announces-appointment-of-darren-cline-to-the-board-of-directors,SGEN,0.054794,Neutral,0.008984
Marinus  ( MRNS )  to Sell Rare Disease PRV to Novo Nordisk,20220715T154300,https://www.zacks.com/stock/news/1953027/marinus-mrns-to-sell-rare-disease-prv-to-novo-nordisk,SGEN,0.254307,Neutral,0.083778
Vaxcyte  ( PCVX )  Completes Enrollment in Pneumococcal Disease Study,20220714T155900,https://www.zacks.com/stock/news/1952493/vaxcyte-pcvx-completes-enrollment-in-pneumococcal-disease-study,SGEN,0.246582,Neutral,0.073851
Rhythm  ( RYTM )  Surges on Upbeat Data on Lead Product Candidate,20220713T161500,https://www.zacks.com/stock/news/1951929/rhythm-rytm-surges-on-upbeat-data-on-lead-product-candidate,SGEN,0.247208,Neutral,0.096362
Pliant Therapeutics  ( PLRX )  Up on Positive Data From Lung Disease Study,20220712T150100,https://www.zacks.com/stock/news/1951160/pliant-therapeutics-plrx-up-on-positive-data-from-lung-disease-study,SGEN,0.282234,Somewhat-Bullish,0.152928
